The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials

Published:2021-02 Issue: Volume:893 Page:173823
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Nowrouzi-Sohrabi Peyman^ORCID,Rezaei Shahla,Jalali Mohammad^ORCID,Ashourpour Mahkameh,Ahmadipour Ahmad,Keshavarz Pedram^ORCID,Akbari Hamed

Publisher

Elsevier BV

Subject

Pharmacology

Reference56 articles.

1. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study;Armstrong;Lancet,2016

2. Downregulation of IL‐22 can be considered as a risk factor for onset of type 2 diabetes;Asadikaram;J. Cell. Biochem.,2018

3. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2018;Association;Diabetes Care,2018

4. Vildagliptin more effectively achieves a composite endpoint of HbA1c< 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment;Bader;Diabetes Res. Clin. Pract.,2013

5. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of glucagon-like peptide-1 receptor agonists on body composition and anthropometric indices: A protocol for a systematic review and network meta-analysis of randomized controlled trials;PLOS ONE;2024-02-26

2. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association;Circulation;2024-02-20

3. Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head meta-analysis;Medicine;2023-10-27

4. Crosstalk between autophagy and insulin resistance: evidence from different tissues;European Journal of Medical Research;2023-10-25

5. Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association;Circulation;2023-02-21